Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
Tirzepatide ODT has not undergone clinical trials
The FDA's Pharmacy Compounding Advisory Committee is scheduled to meet on July 23 and July 24, 2026 to discuss whether several peptide-related bulk drug substances should be considered for the Section 503A bulk drug substances list
Researched for its potential wellness benefits, this peptide may help you feel stronger, more balanced, and ready to move forward
See our full peptide therapy services and pricing page for details on all available peptides
Semaglutide (STEP 1 trial): Participants lost an average of 14.9% of body weight over 68 weeks at the 2.4 mg dose, compared to 2.4% with placebo
US$ 22.08
US$ 25.49
US$ 27.94
US$ 28.45
US$ 23.42
US$ 26.12
US$ 23.17
